Autor
Afiliación
Resumen en ingles
Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents disease progression and reduces sexual transmission of human immunodeficiency virus (HIV). We describe the temporal trends in CD4 cell counts at the start of cART in adults from low-income, lower-middle-income, upper-middle-income, and high-income countries (LICs, LMICs, UMICs, and HICs, respectively).
Editor
Oxford
Referencia
IeDEA and COHERE Cohort Collaborations. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clinical infectious diseases, v. 66, n. 6, p. 893-903, 2018.
DOI
10.1093/cid/cix915
ISSN
1058-4838
Notas
Te writing committee included the following:
Nanina Anderegg (Institute of Social and Preventive Medicine, University
of Bern, Switzerland), Klea Panayidou (Institute of Social and Preventive
Medicine, University of Bern, Switzerland), Yao Abo (Programme PAC-CI,
Centre Hospitalier Universitaire de Treichville, Abidjan, Côte d’Ivoire),
Belen Alejos (National Center of Epidemiology, Instituto de Salud Carlos
III, Madrid, Spain), Keri N. Althoff (Department of Epidemiology, Johns
Hopkins Bloomberg School of Public Health, Baltimore, Maryland), Kathryn
Anastos (Departments of Medicine and Epidemiology & Population Health,
Albert Einstein College of Medicine, Bronx NY), Andrea Antinori (HIV/
AIDS Department, National Institute for Infectious Diseases L. Spallanzani,
IRCCS, Rome, Italy), Eric Balestre (Centre INSERM U1219, Bordeaux
Population Health, Université de Bordeaux, France), Renaud Becquet
(INSERM, Centre de Recherche INSERM U1219 and Institut de Santé
Publique Epidémiologie Développement, Université Bordeaux, France),
Antonella Castagna (Department of Infectious Diseases, San Raffaele
Scientifc Institute, University Vita-Salute San Raffaele, Milan, Italy),
Barbara Castelnuovo (Infectious Diseases Institute, Makerere University,
Mulago Hospital, Kampala, Uganda), Geneviève Chêne (INSERM, ISPED,
Centre INSERM U1219-Bordeaux Population Health, Bordeaux, France),
Lara Coelho (Fundação Oswaldo Cruz, Instituto de Pesquisa Clinica Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS, Rio de Janeiro, Brasil), Intira Jeannie Collins (Medical
Research Council [MRC] Clinical Trials Unit, Institute of Clinical Trials &
Methodology, University College London, United Kingdom), Dominique
Costagliola (Sorbonne Universites, UPMC Université Paris 06, INSERM,
Institut Pierre Louis d’Epidemiologie et de Sante Publique, Paris, France),
Brenda Crabtree-Ramírez (Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City,
Mexico), Francois Dabis (INSERM, Centre de Recherche INSERM U1219
and Institut de Santé Publique Epidémiologie Développement, Université
Bordeaux, France), Antonella d’Arminio Monforte (Clinic of Infectious and
Tropical Diseases, Department of Health Sciences, ASST Santi Paolo e Carlo,
University of Milan, Italy), Mary-Ann Davies (Centre for Infectious Disease
Epidemiology and Research, School of Public Health and Family Medicine,
University of Cape Town, South Africa), Stéphane De Wit (Department
of Infectious Diseases, St Pierre University Hospital, Université Libre de
Bruxelles, Brussels, Belgium), Valérie Delpech (Public Health England,
London, United Kingdom), Nicole L. De La Mata (Te Kirby Institute,
UNSW Sydney, New South Wales, Australia), Stephany Duda (Department
of Biomedical Informatics, Vanderbilt University Medical Center, Nashville,
Tennessee), Aimee Freeman (Department of Epidemiology, Johns Hopkins
Bloomberg School of Public Health, Baltimore, Maryland), Stephen J. Gange
(Department of Epidemiology, Johns Hopkins Bloomberg School of Public
Health, Baltimore, Maryland), Katharina Grabmeier-Pfstershammer
(Division of Immunology, Allergy and Infectious Diseases, Department
of Dermatology, Medical University of Vienna, Austria), Barbara
Gunsenheimer-Bartmeyer (Robert Koch Institute, Berlin, Germany),
Awachana Jiamsakul (Te Kirby Institute, UNSW Sydney, New South
Wales, Australia), Mari M. Kitahata (Center for AIDS Research, University
of Washington, Seattle), Matthew Law (Te Kirby Institute, UNSW Sydney,
New South Wales, Australia), Christian Manzardo (Infectious Diseases
Service, Hospital Clinic-IDIBAPS, University of Barcelona, Spain),
Catherine McGowan (Division of Infectious Diseases, Vanderbilt University
Medical Center, Nashville, Tennessee), Laurence Meyer (Université Paris
Sud, Le Kremlin-Bicêtre, France), Richard Moore (Department of Medicine,
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland),
Cristina Mussini (Clinic of Infectious Diseases, University of Modena
and Reggio Emilia, Italy), Gertrude Nakigoz (Rakai Health Sciences
Program, Uganda), Denis Nash (Institute for Implementation Science
in Population Health, City University of New York and Graduate School
of Public Health and Health Policy, City University of New York), Oon
Tek Ng (Tan Tock Seng Hospital, Singapore), Niels Obel (Department of
Infectious Diseases, Rigshospitalet, University of Copenhagen, Denmark),
Nikos Pantazis (Department of Hygiene, Epidemiology and Medical
Statistics, Medical School, National and Kapodistrian University of Athens,
Greece), Armel Poda (Institut Supérieur des Sciences de la Santé, Université
Polytechnique de Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso), Dorthe
Raben (Department of Infectious Diseases, Rigshospitalet, University
of Copenhagen, Denmark), Peter Reiss (Stichting HIV Monitoring and
Department of Global Health and Division of Infectious Diseases, Academic
Medical Center, University of Amsterdam, the Netherlands), Larry Riggen
(Department of Biostatistics, Indiana University Fairbanks School of Public
Health, Indianapolis), Caroline Sabin (Research Department of Infection
and Population Health, University College London, United Kingdom),
Jean d’Amour Sinayobye (Division of Research and Clinical Education,
Te Rwanda Military Hospital, Kanombe, Kigali), Anders Sönnerborg
(Karolinska Institutet and Karolinska University Hospital, Stockholm,
Sweden), Marcel Stoeckle (Division of Infectious Diseases and Hospital
Epidemiology, University Hospital Basel and University Basel, Switzerland),
Claire Torne (Great Ormond Street Institute of Child Health, University
College London, United Kingdom), Carlo Torti (Infectious and Tropical
Diseases Unit, Department of Medical and Surgical Sciences, University
“Magna Graecia” of Catanzaro, Italy), Christella Twizere (Centre HospitaloUniversitaire de Kamenge, Bujumbura, Burundi), Jan-Christian Wasmuth
(Department of Internal Medicine I, University of Bonn, Germany), Linda
Wittkop (INSERM, Centre de Recherche INSERM U1219 and Institut
de Santé Publique Epidémiologie Développement, Université Bordeaux,
France), Kara Wools-Kaloustian (Division of Infectious Diseases, Indiana
University School of Medicine, Indianapolis), Marcel Yotebieng (Division of
Epidemiology, College of Public Health, Ohio State University, Columbus),
Ole Kirk (CHIP, Department of Infectious Diseases, Rigshospitalet,
University of Copenhagen, Denmark), and Matthias Egger (Institute of
Social and Preventive Medicine, University of Bern, Switzerland, and
(Centre for Infectious Disease Epidemiology and Research, School of Public
Health and Family Medicine, University of Cape Town, South Africa).
Compartir